FDA Inspection
Galbraith Laboratories IncGalbraith Laboratories Inc – FDA Inspection, Jun 16, 2026
Record Details
This FDA Inspection record concerns Galbraith Laboratories Inc, with an inspection on June 16, 2026, issued by the New Orleans District Office, covering human drugs.
- Company
- Galbraith Laboratories Inc
- Inspection Date
- June 16, 2026
- Product Type
- Human Drugs
View Company Profile
ID · 4080e79f-f658-4d35-ae2f-7046ba3b9ea2
Inspection Facts
- Inspection number
- 1322240
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Galbraith Laboratories Inc
7| Date | Classification | Office | Project area |
|---|---|---|---|
| November 16, 2023 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| March 2, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 1, 2016 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| December 3, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 11, 2014 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Galbraith Laboratories Inc
- FDA Inspection 1222900 - 2023-11-16
- FDA Inspection 1163571 - 2022-03-02
- FDA Inspection 993886 - 2016-12-01
- FDA Inspection 905657 - 2014-12-03
- FDA Inspection 867685 - 2014-02-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.